Total Payments
$10,262
2024 Payments
$1,900
Companies
38
Transactions
642
Medicare Patients
3,882
Medicare Billing
$502,082
Payment Breakdown by Category
Food & Beverage$10,191 (99.3%)
Education$71.17 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,191 | 640 | 99.3% |
| Education | $71.17 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,034 | 194 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,634 | 100 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $754.21 | 48 | $0 (2024) |
| Janssen Biotech, Inc. | $637.26 | 40 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $517.98 | 36 | $0 (2024) |
| Merck Sharp & Dohme LLC | $422.21 | 22 | $0 (2024) |
| Braintree Laboratories, Inc. | $340.31 | 21 | $0 (2024) |
| GENZYME CORPORATION | $291.34 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $245.05 | 12 | $0 (2024) |
| PFIZER INC. | $207.33 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,900 | 105 | ABBVIE INC. ($625.37) |
| 2023 | $1,929 | 107 | AbbVie Inc. ($636.70) |
| 2022 | $1,553 | 87 | ABBVIE INC. ($571.01) |
| 2021 | $926.48 | 54 | AbbVie Inc. ($289.68) |
| 2020 | $489.70 | 30 | AbbVie Inc. ($163.40) |
| 2019 | $1,289 | 96 | Takeda Pharmaceuticals U.S.A., Inc. ($382.83) |
| 2018 | $1,396 | 110 | AbbVie, Inc. ($293.26) |
| 2017 | $779.13 | 53 | AbbVie, Inc. ($136.45) |
All Payment Transactions
642 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.49 | General |
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/21/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/20/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Immunology | ||||||
| 11/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $45.24 | General |
| Category: LIVER DISEASE | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Immunology | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Immunology | ||||||
| 10/21/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: GI | ||||||
| 10/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/14/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/07/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Oncology / Rare Diseases | ||||||
| 09/28/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Immunology | ||||||
| 09/23/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.37 | General |
| Category: GI | ||||||
| 09/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 799 | 919 | $398,012 | $98,695 |
| 2022 | 19 | 1,010 | 1,177 | $483,733 | $131,436 |
| 2021 | 18 | 1,086 | 1,318 | $540,359 | $156,222 |
| 2020 | 22 | 987 | 1,165 | $460,368 | $115,729 |
Total Patients
3,882
Total Services
4,579
Medicare Billing
$502,082
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 76 | 76 | $71,060 | $15,604 | 22.0% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 34 | 69 | $40,365 | $13,837 | 34.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 84 | 86 | $26,316 | $11,626 | 44.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 81 | 84 | $64,848 | $8,073 | 12.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 119 | $16,303 | $7,576 | 46.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 37 | 37 | $25,826 | $6,717 | 26.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 57 | 58 | $34,974 | $5,125 | 14.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 75 | 130 | $7,670 | $5,033 | 65.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $9,139 | $4,524 | 49.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 29 | 29 | $26,013 | $3,806 | 14.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 21 | 21 | $14,679 | $3,736 | 25.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $15,356 | $3,248 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 31 | $6,045 | $2,872 | 47.5% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 14 | 14 | $14,140 | $2,068 | 14.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $3,888 | $1,605 | 41.3% |
| 43450 | Dilation of esophagus | Facility | 2023 | 42 | 43 | $16,254 | $1,362 | 8.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 27 | $2,268 | $1,016 | 44.8% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 12 | 12 | $2,868 | $867.62 | 30.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 156 | 158 | $48,348 | $24,457 | 50.6% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 47 | 92 | $53,820 | $20,662 | 38.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 98 | 98 | $91,630 | $19,965 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 169 | $23,153 | $11,014 | 47.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 86 | 88 | $67,936 | $8,337 | 12.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 41 | 41 | $28,618 | $7,755 | 27.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 63 | 64 | $38,592 | $5,796 | 15.0% |
About Dr. Michael Zelig, MD
Dr. Michael Zelig, MD is a Gastroenterology healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1578561197.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Zelig, MD has received a total of $10,262 in payments from pharmaceutical and medical device companies, with $1,900 received in 2024. These payments were reported across 642 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($10,191).
As a Medicare-enrolled provider, Zelig has provided services to 3,882 Medicare beneficiaries, totaling 4,579 services with total Medicare billing of $502,082. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Pensacola, FL
- Active Since 07/08/2005
- Last Updated 07/21/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1578561197
Products in Payments
- ENTYVIO (Biological) $679.58
- Linzess (Drug) $669.15
- RINVOQ (Biological) $610.30
- STELARA (Biological) $576.86
- DUPIXENT (Biological) $536.39
- SKYRIZI (Biological) $398.25
- Entyvio (Biological) $387.28
- MAVYRET (Drug) $367.61
- XIFAXAN (Drug) $364.62
- DIFICID (Drug) $356.34
- LINZESS (Drug) $356.16
- Humira (Biological) $330.52
- VIBERZI (Drug) $298.73
- CREON (Drug) $281.20
- SUPREP (Drug) $262.95
- HUMIRA (Biological) $250.63
- GATTEX (Drug) $249.34
- Creon (Drug) $226.04
- Trulance (Drug) $198.54
- ZENPEP (Drug) $191.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Pensacola
Dr. Benjamin Tharian, Md Mrcp Fracp, MD MRCP FRACP
Gastroenterology — Payments: $42,592
Gastroenterology $42,592
Frederic Newman, Md, MD
Gastroenterology — Payments: $32,704
Gastroenterology $32,704
Dr. Donald Denby, M.d, M.D
Gastroenterology — Payments: $9,755
Gastroenterology $9,755
Dr. Ronald Powell, Md, MD
Gastroenterology — Payments: $8,112
Gastroenterology $8,112
Patrick Reilly, Md, MD
Gastroenterology — Payments: $6,928
Gastroenterology $6,928
Dr. Samer Al-Shurieki, Md, MD
Gastroenterology — Payments: $6,794
Gastroenterology $6,794